The CTFA evaluation of alternatives program: An evaluation of in vitro alternatives to the draize primary eye irritation test. (Phase II) oil/water emulsions

Food and Chemical Toxicology

Volumn 32, Issue 10, 1994, Pages 943-976

  Gettings, S D ^a   Dipasquale, L C ^b   Bagley, D M ^c   Casterton, P L ^d   Chudkowski, M ^e   Curren, R D ^f   Demetrulias, J L ^g   Feder, P I ^h   Galli, C L ⁱ   Gay, R ^j   Glaza, S M ^k   Hintze, K L ^l   Janus, J ^m   Kurtz, P J ^h   Lordo, R A ^h   Marenus, K D ⁿ   Moral, J ^o   Muscatiello, M ^p   Pape, W J W ^q   Renskers, K J ^r   Roddy, M T ^s   Rozen, M G ^t   more..

^a and Fragrance Association   (United States)

^b Gillette Medical Evaluation Lab   (United States)

^c Oral Care Research and Development   (United States)

^d Amway Corporation   (United States)

^e JOHNSON AND JOHNSON   (United States)

^f Microbiological Associates Inc   (United States)

^g Dial Corporation   (United States)

^h BATTELLE MEMORIAL INSTITUTE   (United States)

ⁱ UNIPRO Res Ctr Cosmetic Toxicol   (Italy)

^j ORGANOGENESIS INC   (United States)

^k Hazleton Wisconsin   (United States)

^l PROCTER AND GAMBLE COMPANY   (United States)

^m Clonetics Corporation   (United States)

ⁿ Estee Lauder Inc   (United States)

^o Revlon Research Center   (United States)

^p L ORÉAL RECHERCHE   (France)

^q BEIERSDORF AG   (Germany)

^r Avon Products Inc   (United States)

^s Noxell Corp ^*  (United States)

^t MARY KAY INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

WATER OIL CREAM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG TOXICITY; EMULSION; EYE IRRITATION; IN VITRO STUDY; NONHUMAN; RABBIT; TOXICITY TESTING;

3T3 CELLS; ANIMAL; ANIMAL TESTING ALTERNATIVES; CELLS, CULTURED; CHICK EMBRYO; COMPARATIVE STUDY; COSMETICS; DATA INTERPRETATION, STATISTICAL; DRUG EVALUATION; EVALUATION STUDIES; EYE; FEMALE; HAIR PREPARATIONS; IMMUNODIFFUSION; IN VITRO; MALE; MICE; NEUTRAL RED; OCULAR PHYSIOLOGY; PHOTOBACTERIUM; PROTEIN CONFORMATION; PROTEINS; RABBITS; RANDOM ALLOCATION; REGRESSION ANALYSIS; SKIN; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0028171303     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-6915(94)90092-2     Document Type: Article

References (47)

1. Comparisons of the cytotoxicities of dermatotoxicants to human keratinocytes and fibroblasts in vitro
2. Factors affecting use of the hen's egg chorioallantoic membrane as a model for predicting eye irritation potential: I
3. Evaluation of the vascular components of the chorioallantoic membrane assay as a model for eye irritation potential: II
4. Use of fabricated living tissue and organ equivalents as defined higher order systems for the study of pharmacologic responses to test substances
5. Comparison of two in vitro cytotoxicity assays—the neutral red (NR) and tetrazolium MTT tests
6. Toxicity determined in vitro by morphological alterations and neutral red absorption
7. Evaluation of seven in vitro alternatives for ocular safety testing
8. Bioluminescence assays
9. In vitro cytotoxicity of 150 chemicals to 3T3-L1 cells, assessed by the FRAME kenacid blue method
10. Describing the validity of carcinogen screening tests
11. The Bootstrap
12. Labelling requirements for pesticides and devices, proposed rule
13. The CTFA Evaluation of Alternatives Program, an evaluation of in vitro alternatives to the Draize primary eye irritation test
14. CTFA Evaluation of Alternatives Program: statistical approach
15. ATP and protein synthesis assays to evaluate the toxicity of preservatives in vitro
16. The living dermal equivalent as an in vitro model for predicting ocular irritation
17. Update on in vitro alternatives development
18. Development of potential alternatives to the Draize eye test: the CTFA Evaluation of Alternatives Program
19. Flow analysis-hydride generation-gas phase derivative molecular absorption spectrophotometric determination of antimony in oral homeopathic products ("AntimoniumTartaricum") formulated under alcoholic medium.
20. Development of potential alternatives to the Draize eye test: the CTFA Evaluation of Alternatives Program
21. The CTFA Evaluation of Alternatives Program: an evaluation of in vitro alternatives to the Draize primary eye irritation test (Phase I) hydroalcoholic formulations
22. tm third generation
23. EYTEX: an in vitro method for evaluation of ocular irritancy
24. Direct simulation
25. A national validation project of alternative methods to the Draize rabbit eye test
26. Validation project of alternatives for the Draize eye test
27. Photometric quantitation of in vitro pollen tube growth: a new method suited to determine the cytotoxicity of various environmental substances
28. Interpretation of eye irritation tests
29. The FRAME multicentre project on in vitro cytotoxicology
30. Protein measurement with the Folin phenol reagent
31. Hen's egg chorioallantoic membrane test for irritation potential
32. HET-CAM—an alternative to the Draize eye test
33. Quantification of in vitro cytotoxicity of surfactants: correlation with their eye irritation potential
34. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
35. Evaluation of an in vitro cell toxicity test using rabbit corneal cells to predict the eye irritation potential of surfactants
36. Epidermis generated in vitro: practical considerations and applications
37. A vital dye release method for assessing the short-term cytotoxic effects of chemicals and formulations
38. An in vitro cytotoxicity test to predict the ocular irritation potential of detergents and detergent products
39. Rapid cytotoxicity testing using a semi-automated protein determination on cultured cells
40. Evaluation of Tetrahymena thermophila as an in vitro alternative to ocular irritation studies in rabbits
41. Arachidonic acid metabolism in HEL/30 murine epidermal cell line
42. The agarose diffusion method for ocular irritancy screening: cosmetic products, Part I
43. Evaluation of ocular irritancy potential: interlaboratory variability and effect of dosage volume